// App-Quantinova.ai

391 : Lrg1 blockade modulates the tumor immune microenvironment and improves the efficacy of cancer therapeutics

Researchers

Presenter

  • Carlotta Camilli

Principal Investigators

  • Camilla Pilotti

  • Marie N. O'Connor

  • David Kallenberg

  • Markella Alatsatianos

  • Angharad H. Watson

  • Julia Ohme

  • Athina Dritsoula

  • Ann Ager

  • Stephen E. Moss

  • John Greenwood

Medical Centers

  • UCL, Institute of Ophthalmology, London, United Kingdom

  • Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Influenza

  • Melanoma

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of differentiation 8A

  • Granzyme B

  • Leucine Rich Alpha-2-Glycoprotein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved